Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCastelnau Group Regulatory News (CGL)

Share Price Information for Castelnau Group (CGL)

Share Price is delayed by 15 minutes
Get Live Data
89.50    0.00 (0.00%)
Bid:
88.00
Ask:
91.00
Spread: 3.00 (3.409%)
Market Cap: £298.49m
CGL Live PriceLast checked at - London Stock Exchange

Intraday Castelnau Group Share Chart

Performance Fee Arrangements Update

31 May 2024 07:00

Castelnau Group Ltd - Performance Fee Arrangements Update

Castelnau Group Ltd - Performance Fee Arrangements Update

PR Newswire

LONDON, United Kingdom, May 31

LEI: 213800PED8RFUBMK1T64

31 May 2024

Castelnau Group Limited(“Castelnau” or the “Company”)

Performance Fee Arrangements Update

The Board of the Company announces, that as detailed in its Annual Report published on 19 April 2024, it has reviewed the performance fee arrangements under the investment management agreement with Phoenix Asset Management Partners Limited (the “Investment Manager”) dated 23 September 2021 (the “IMA”) and have today entered into a restated and amended investment management agreement (the “Revised IMA”) which includes a number of minor amendments to the way the performance fee is calculated.

Summary of changes

The Investment Manager does not charge a management fee to Castelnau and is instead incentivised solely via a performance based fee arrangement. In summary, the performance fee arrangement is measured over consecutive periods of not less than three years with first period commencing on the Company’s IPO on 18 October 2021 and ending on 31 December 2024. The performance fee payable is one third of the outperformance of the Net Asset Value total return after adjustment for inflows and outflows, over the FTSE All-Share Total Return Index (the “Benchmark”) with, subject to certain regulatory considerations, the performance fee being satisfied through the issuance of new ordinary shares.

The directors believe that the performance fee, measured over a three year period and receivable in shares, remains a significant point of alignment between the Company, its shareholders and the Investment Manager; however, the performance fee arrangement has been reviewed to ensure this alignment is equitable to all parties. Pursuant to the terms of the IMA, the performance fee is paid based on the outperformance over the Benchmark, calculated by reference to the ‘average’ adjusted net assets of the Company over each performance period. The averaging of the net asset value over the performance period does not fully take into account the outperformance that has been delivered by the Investment Manager and principally for this reason a limited number of adjustments are being made to the IMA, with the revisions summarised below:

The fee will remain as one third of the outperformance over the Benchmark, however, the fee will be calculated by reference to the closing net asset value (“Closing NAV”) rather than the average net asset value, and will be compared to the ‘Benchmark NAV’.The Closing NAV is the reported net asset value of the Company at the period end, excluding any accrued performance fees. This will be compared to the Benchmark NAV, which is the Company’s opening NAV for the performance period to which the Benchmark return is applied. The Benchmark NAV will also be adjusted for the impact of inflows and outflows to the share capital of the Company, to ensure that both the Closing NAV and Benchmark NAV reflect performance adjusted for the impact of these events.

For the avoidance of doubt, no performance fee for the period to 31 December 2024 would currently be payable under either the original or revised performance fee calculation. In addition, no additional changes under the Revised IMA (other than in respect of the performance fee) are being made.

As an SFS company CGL is not required to comply with the provisions of Chapter 11 of the Listing Rules regarding related party transactions. However, the Company have adopted a related party policy which applies to any transaction which it may enter into with any Director, the Manager or any of their affiliates, which would constitute a “related party transaction” as defined in, and to which would apply, Chapter 11 of the Listing Rules. In accordance with the Company’s related party policy the independent directors of the Company have considered the terms of the Revised IMA and have confirmed that they consider the changes to be fair and reasonable.

Enquiries:

Castelnau GroupRichard Brown - CEOinfo@castelnaugroup.com

Phoenix Asset Management Limited+44 (0) 208 600 0100Gary ChannonSteve TattersGina Bocek

Liberum Capital Limited+44 (0) 20 3100 2000Darren VickersOwen MatthewsWill King

Citigate Dewe Rogerson+44 (0) 20 7638 9571Caroline MerrellToby Moore

Northern Trust International Fund Administration Services (Guernsey) LimitedThe Company SecretaryTrafalgar CourtLes BanquesSt Peter PortGuernseyGY1 3QLTel: 01481 745001

 



Date   Source Headline
6th Mar 20142:35 pmRNSHolding(s) in Company
3rd Mar 20143:11 pmRNSTotal Voting Rights
21st Feb 201411:25 amRNSPurchase by EBT
19th Feb 20145:02 pmRNSPurchase by EBT
17th Feb 20144:03 pmRNSPurchase by EBT
13th Feb 20142:37 pmRNSHolding(s) in Company
12th Feb 20146:00 pmRNSPurchase by EBT
12th Feb 201412:12 pmRNSDirector/PDMR Shareholding
11th Feb 20146:23 pmRNSPurchase by EBT
10th Feb 20149:00 amRNSDividend Declaration
10th Feb 20147:00 amRNSFinal Results
6th Feb 20149:55 amRNSHolding(s) in Company
3rd Feb 201412:38 pmRNSTotal Voting Rights
7th Jan 20147:00 amRNSSingapore Branch
3rd Jan 20145:00 pmRNSTotal Voting Rights
2nd Jan 20145:04 pmRNSBlocklisting Interim Review
2nd Jan 20143:44 pmRNSDirector/PDMR Shareholding
23rd Dec 201311:58 amRNSDirector/PDMR Shareholding
25th Nov 20139:00 amRNSFinancial Calendar
19th Nov 20133:42 pmRNSDirector/PDMR Shareholding
11th Nov 20137:00 amRNSInterim Management Statement
1st Nov 201311:45 amRNSTotal Voting Rights
31st Oct 20138:27 amRNSInvestor Day
29th Oct 201311:40 amRNSAdditional Listing
1st Oct 20135:13 pmRNSTotal Voting Rights
27th Sep 20134:22 pmRNSDirector/PDMR Shareholding
24th Sep 20135:40 pmRNSDirector/PDMR Shareholding
2nd Sep 201311:28 amRNSTotal Voting Rights
15th Aug 20134:31 pmRNSDirector/PDMR Shareholding
9th Aug 20139:00 amRNSDividend Declaration
9th Aug 20137:00 amRNSHalf Yearly Report
1st Aug 201311:35 amRNSTotal Voting Rights
1st Jul 201312:35 pmRNSBlocklisting Interim Review
1st Jul 201312:31 pmRNSTotal Voting Rights
19th Jun 20133:15 pmRNSDirector/PDMR Shareholding
14th Jun 20135:06 pmRNSDirector/PDMR Shareholding
6th Jun 201310:28 amRNSDirector/PDMR Shareholding
3rd Jun 201312:55 pmRNSTotal Voting Rights
28th May 201312:20 pmRNSDirector/PDMR Shareholding
22nd May 20133:35 pmRNSDirector/PDMR Shareholding
10th May 20137:00 amRNSResult of AGM
10th May 20137:00 amRNSInterim Management Statement
1st May 20139:39 amRNSTotal Voting Rights
24th Apr 20136:10 pmRNSDirector/PDMR Shareholding
17th Apr 20133:45 pmRNSDisclosure of New Directorship
9th Apr 20134:48 pmRNSDirector/PDMR Shareholding
5th Apr 20135:12 pmRNSNotice of AGM
2nd Apr 20132:12 pmRNSTotal Voting Rights
28th Mar 20132:09 pmRNSDirector/PDMR Shareholding
28th Mar 20139:47 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.